Page last updated: 2024-12-08

4-amidinophenylpyroracemic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

amidinophenylpyruvic acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151496
SCHEMBL ID4092888
MeSH IDM0049087

Synonyms (9)

Synonym
amidinophenylpyruvic acid
4-amino-4-imino-2-oxo-3-phenylbutanoic acid
benzenepropanoic acid, 4-(aminoiminomethyl)-alpha-oxo-
10290-63-8
4-appa
4-amidinophenylpyroracemic acid
4-amidinophenylpyruvic acid
SCHEMBL4092888
DTXSID60908114

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" APPA inhibits as well the maternal as by diaplacental passage the fetal hemostasis in dependence on the dosage till the incoagulability."( [Diaplacental inhibition of fetal blood coagulation in pregnant sheep (author's transl)].
Hofmann, KD; Jäger, K; Kukuk, G; Laube, R; Niedner, W; Weller, E, 1980
)
0.26
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (84.21)18.7374
1990's3 (15.79)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.30 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]